---
output: 
  md_document:
    variant: gfm  # GitHub-flavored Markdown (for better rendering on GitHub)
    preserve_yaml: true  # Keep YAML metadata in the output
params:
  trial: ''
---

**NCT04862663**

<div style="padding: 5px; font-size: 1.20em; font-weight: bold; color: #2E4A7F; text-align: left; margin-bottom: 20px">

(CAPItello-292) Estudo de Fase Ib/III, aberto e randomizado, comparando
Capivasertib mais inibidores de CDK4/6 e Fulvestrant versus inibidores
de CDK4/6 e Fulvestrant em câncer de mama avançado HR+ HER2-.

</div>

**Título Oficial:**: A Phase Ib/III, Open-label, Randomised Study of
Capivasertib Plus CDK4/6 Inhibitors and Fulvestrant Versus CDK4/6
Inhibitors and Fulvestrant in Hormone Receptor-Positive and Human
Epidermal Growth Factor Receptor 2-Negative Locally Advanced,
Unresectable or Metastatic Breast Cancer (CAPItello-292)

**Desenho do Estudo:**: Estudo Clinico Fase III

**Resumo do Estudo:**: O estudo CAPItello-292 é um ensaio de Fase
Ib/III, aberto e randomizado, que compara a eficácia do Capivasertib
combinado com inibidores de CDK4/6 e Fulvestrant contra o tratamento
padrão de inibidores de CDK4/6 e Fulvestrant. A população-alvo inclui
pacientes com câncer de mama localmente avançado, irressecável ou
metastático, positivo para receptor hormonal e negativo para receptor 2
do fator de crescimento epidérmico humano. O estudo visa avaliar se a
adição de Capivasertib melhora os resultados do tratamento neste grupo
específico de pacientes.

**Paciente Ideal:**: O estudo CAPItello-292 é um ensaio de Fase Ib/III,
aberto e randomizado, que compara a eficácia do Capivasertib combinado
com inibidores de CDK4/6 e Fulvestrant contra o tratamento padrão de
inibidores de CDK4/6 e Fulvestrant. A população-alvo inclui pacientes
com câncer de mama localmente avançado, irressecável ou metastático,
positivo para receptor hormonal e negativo para receptor 2 do fator de
crescimento epidérmico humano. O estudo visa avaliar se a adição de
Capivasertib melhora os resultados do tratamento neste grupo específico
de pacientes.

Para mais informações, acesse as informações do estudo no
*clinicaltrials.gov* no seguinte
[link](https://clinicaltrials.gov/ct2/show/NCT04862663)

**Centros Participantes**

<div style="margin-bottom: 8px; margin-left: 5px; padding: 8px; max-width: 300px; background-color: #f3f2f1; border-radius: 8px;">

<div style="margin-left: 10px;">

    <span 
      style="background-color: green; width: 15px; height: 15px; display: inline-block; margin-right: 5px; border-radius: 50%;"></span>
    <p style="display: inline;">Recrutamento Ativo</p>

</div>

<div style="margin-left: 10px;">

    <span 
      style="background-color: yellow; width: 15px; height: 15px; display: inline-block; margin-right: 5px; border-radius: 50%;"></span>
    <p style="display: inline;">Ainda Não Recrutando</p>

</div>

<div style="margin-left: 10px;">

    <span 
      style="background-color: red; width: 15px; height: 15px; display: inline-block; margin-right: 5px; border-radius: 50%;"></span>
    <p style="display: inline;">Recrutamento Suspenso/Encerrado</p>

</div>

</div>

<span style="display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: green;"></span>
ES Hospital Santa Rita 29043-260, Vitória
<span style="color: #2E4A7F; text-decoration: none; font-weight: 500; font-size: 0.8">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT04862663&location_id=RESEARCHSITEVITORIA29043260BRAZIL&location_full_name=Hospital%20Santa%20Rita%2C%2029043-260%2C%20Vit%C3%B3ria&form_type=Reportar%20Erro)</span>

<span style="display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: green;"></span>
MG Centro de Oncologia de Alfenas 37130-087, Alfenas
<span style="color: #2E4A7F; text-decoration: none; font-weight: 500; font-size: 0.8">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT04862663&location_id=RESEARCHSITEALFENAS37130000BRAZIL&location_full_name=Centro%20de%20Oncologia%20de%20Alfenas%2C%2037130-087%2C%20Alfenas&form_type=Reportar%20Erro)</span>

<span style="display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: green;"></span>
PI Oncoclínica Oncologistas Associados 64049-200, Teresina
<span style="color: #2E4A7F; text-decoration: none; font-weight: 500; font-size: 0.8">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT04862663&location_id=RESEARCHSITETERESINA64049200BRAZIL&location_full_name=Oncocl%C3%ADnica%20Oncologistas%20Associados%2C%2064049-200%2C%20Teresina&form_type=Reportar%20Erro)</span>

<span style="display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: green;"></span>
RN Centro Avançado de Oncologia (CECAN) 59062-000, Natal
<span style="color: #2E4A7F; text-decoration: none; font-weight: 500; font-size: 0.8">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT04862663&location_id=RESEARCHSITENATAL59075740BRAZIL&location_full_name=Centro%20Avan%C3%A7ado%20de%20Oncologia%20%28CECAN%29%2C%2059062-000%2C%20Natal&form_type=Reportar%20Erro)</span>

<span style="display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: green;"></span>
RO Hospital de Amor Amazônia 76834-899, Porto Velho
<span style="color: #2E4A7F; text-decoration: none; font-weight: 500; font-size: 0.8">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT04862663&location_id=RESEARCHSITEPORTOVELHO76834899BRAZIL&location_full_name=Hospital%20de%20Amor%20Amaz%C3%B4nia%2C%2076834-899%2C%20Porto%20Velho&form_type=Reportar%20Erro)</span>

<span style="display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: green;"></span>
RS Hospital de Clínicas de Porto Alegre 90035-903, Porto Alegre
<span style="color: #2E4A7F; text-decoration: none; font-weight: 500; font-size: 0.8">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT04862663&location_id=RESEARCHSITEPORTOALEGRE90035903BRAZIL&location_full_name=Hospital%20de%20Cl%C3%ADnicas%20de%20Porto%20Alegre%2C%2090035-903%2C%20Porto%20Alegre&form_type=Reportar%20Erro)</span>

<span style="display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: green;"></span>
SC Clínica de Oncologia Reichow 89010-340, Blumenau
<span style="color: #2E4A7F; text-decoration: none; font-weight: 500; font-size: 0.8">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT04862663&location_id=RESEARCHSITEBLUMENAU89010340BRAZIL&location_full_name=Cl%C3%ADnica%20de%20Oncologia%20Reichow%2C%2089010-340%2C%20Blumenau&form_type=Reportar%20Erro)</span>

<span style="display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: green;"></span>
SP Núcleo de Pesquisa e Ensino IBCC Oncologia 04014-002, São Paulo
<span style="color: #2E4A7F; text-decoration: none; font-weight: 500; font-size: 0.8">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT04862663&location_id=RESEARCHSITESAOPAULO04014002BRAZIL&location_full_name=N%C3%BAcleo%20de%20Pesquisa%20e%20Ensino%20IBCC%20Oncologia%2C%2004014-002%2C%20S%C3%A3o%20Paulo&form_type=Reportar%20Erro)</span>

<span style="display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: green;"></span>
SP ICB - Instituto do Câncer Brasil \| Unidade Taubaté \| Oncologista em
Taubaté 12030-200, Taubaté
<span style="color: #2E4A7F; text-decoration: none; font-weight: 500; font-size: 0.8">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT04862663&location_id=RESEARCHSITETAUBATE12030200BRAZIL&location_full_name=ICB%20-%20Instituto%20do%20C%C3%A2ncer%20Brasil%20%7C%20Unidade%20Taubat%C3%A9%20%7C%20Oncologista%20em%20Taubat%C3%A9%2C%2012030-200%2C%20Taubat%C3%A9&form_type=Reportar%20Erro)</span>
